Cargando…
Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) rapidly infects humans and animals which make coronavirus disease 2019 (COVID-19) a grievous epidemic worldwide which broke out in 2020. According to data analysis of the other coronavirus family, for instance severe acute respiratory...
Autores principales: | Liu, Zhi-Mei, Yang, Ming-Hui, Yu, Kun, Lian, Zheng-Xing, Deng, Shou-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518217/ https://www.ncbi.nlm.nih.gov/pubmed/36188605 http://dx.doi.org/10.3389/fphar.2022.989664 |
Ejemplares similares
-
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
por: Chakraborty, Samik, et al.
Publicado: (2023) -
The role of toll-like receptors (TLRs) in pan-cancer
por: Huang, Runzhi, et al.
Publicado: (2022) -
Toll-Like Receptors (TLRs): The Role in Tumor Progression
por: Shcheblyakov, D.V., et al.
Publicado: (2010) -
Toll like Receptors (TLRs) expression in HIV children
por: Madeshwaran, M, et al.
Publicado: (2014) -
Roles of Toll-Like Receptors in Nitroxidative Stress in Mammals
por: Li, Yao, et al.
Publicado: (2019)